Literature DB >> 27813335

Phosphorylation of H2A.XTyr39 positively regulates DNA damage response and is linked to cancer progression.

Yan Liu1,2, Yue-Hong Long1, Shu-Qing Wang3, Yu-Feng Li2, Jing-Hua Zhang2.   

Abstract

Double-stranded DNA breaks induce serine phosphorylation of histone H2A.X, producing γ-H2A.X foci that are then recognized by DNA damage response pathway proteins. Formation of γ-H2A.X is therefore critical for the repair of DNA double-stranded breaks and maintenance of genomic stability, and defects in the recognition or repair of double-stranded breaks can result in tumorigenesis. However, key details regarding the formation of γ-H2A.X and its possible role in tumorigenesis remain elusive. Here, we report a previously unknown phosphorylation site on H2A.X, Tyr39. Phosphorylation at this site is induced by ionizing radiation and is a prerequisite for γ-H2A.X formation. Increased phosphorylation of H2A.X at Tyr39 was observed in multiple cancer cell lines, and we found that H2AX Tyr39 phosphorylation positively correlated with histological grade, tumor size and tumor node metastasis stage, and negatively correlated with survival. We also identified a potential role for eyes absent 2 (EYA2) in regulating H2A.X Tyr39 phosphorylation. Our study supports an important role for H2AX Tyr39 phosphorylation in γ-H2A.X formation and cancer progression.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  DSBs; EYA2; H2A.X; phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 27813335     DOI: 10.1111/febs.13951

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  13 in total

Review 1.  Signaling coupled epigenomic regulation of gene expression.

Authors:  R Kumar; S Deivendran; T R Santhoshkumar; M R Pillai
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

2.  Eya2 promotes cell cycle progression by regulating DNA damage response during vertebrate limb regeneration.

Authors:  Konstantinos Sousounis; Donald M Bryant; Jose Martinez Fernandez; Samuel S Eddy; Stephanie L Tsai; Gregory C Gundberg; Jihee Han; Katharine Courtemanche; Michael Levin; Jessica L Whited
Journal:  Elife       Date:  2020-03-06       Impact factor: 8.140

3.  JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity.

Authors:  Yan Liu; Yue-Hong Long; Shu-Qing Wang; Yuan-Yue Zhang; Yu-Feng Li; Jiang-Sheng Mi; Cheng-Hua Yu; De-Yan Li; Jing-Hua Zhang; Xiao-Jun Zhang
Journal:  Oncogene       Date:  2018-09-05       Impact factor: 9.867

4.  Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells.

Authors:  Jothi Anantharajan; Hengbo Zhou; Lingdi Zhang; Taylor Hotz; Melanie Y Vincent; Melanie A Blevins; Anna E Jansson; John Wee Liang Kuan; Elizabeth Yihui Ng; Yee Khoon Yeo; Nithya Baburajendran; Grace Lin; Alvin W Hung; Joma Joy; Samarjit Patnaik; Juan Marugan; Pratyaydipta Rudra; Debashis Ghosh; Jeffrey Hill; Thomas H Keller; Rui Zhao; Heide L Ford; CongBao Kang
Journal:  Mol Cancer Ther       Date:  2019-07-08       Impact factor: 6.261

5.  Eyes absent homologue 2 predicts a favorable prognosis in colorectal cancer.

Authors:  Jie Zheng; Fuao Cao; Xiaopei Huang; Kuvaneshan Ramen; Xiaowen Xu; Yan Zhu; Wenjun Chang; Yunfeng Shan; Aizhen Guo
Journal:  Onco Targets Ther       Date:  2018-08-08       Impact factor: 4.147

6.  K-ras-ERK1/2 down-regulates H2A.XY142ph through WSTF to promote the progress of gastric cancer.

Authors:  Chao Dong; Jing Sun; Sha Ma; Guoying Zhang
Journal:  BMC Cancer       Date:  2019-05-31       Impact factor: 4.638

Review 7.  Mechanisms of Action for Small Molecules Revealed by Structural Biology in Drug Discovery.

Authors:  Qingxin Li; CongBao Kang
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

8.  Co‑expression of tissue kallikrein 1 and tissue inhibitor of matrix metalloproteinase 1 improves myocardial ischemia‑reperfusion injury by promoting angiogenesis and inhibiting oxidative stress.

Authors:  Shujie Huang; Meixian Chen; Huizhen Yu; Kaiyang Lin; Yansong Guo; Pengli Zhu
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

9.  NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway.

Authors:  Shanyu Fang; Yuanyuan Luo; Ying Zhang; Houmei Wang; Qianfen Liu; Xinya Li; Tinghe Yu
Journal:  Front Cell Dev Biol       Date:  2021-07-01

Review 10.  Jumonji domain-containing protein 6 protein and its role in cancer.

Authors:  Jing Yang; Siyuan Chen; Yanfei Yang; Xuelei Ma; Bin Shao; Shengyong Yang; Yuquan Wei; Xiawei Wei
Journal:  Cell Prolif       Date:  2020-01-21       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.